动脉瘤性蛛网膜下腔出血的侵入性多模态神经监测:系统综述
脑氧张力变化与血管造影血管痉挛或局部脑血流下降相关,乳酸/丙酮酸比值趋势分析可识别延迟性脑缺血高风险患者,皮层扩散性去极化簇与神经功能恶化及脑梗死相关。数据支持在特定患者中使用侵入性神经监测检测延迟性脑缺血,但研究设计偏倚和缺乏随机试验限制了推广。
要点
- 脑组织氧张力变化与血管造影血管痉挛或局部脑血流下降相关。
- 脑微透析乳酸/丙酮酸比值趋势分析可识别延迟性脑缺血高风险患者。
- 皮层扩散性去极化簇与神经功能恶化及脑梗死相关。
核心结论
- 数据支持在特定患者中使用侵入性神经监测检测延迟性脑缺血。
- 连续数据记录与趋势分析及多模态联合可为高风险患者提供个体化治疗支持。
研究设计与样本
- 监测技术包括脑组织氧张力(N=21)、脑微透析(N=22)和皮层脑电图(N=4)。
主要发现
- 脑氧张力变化与血管造影血管痉挛或局部脑血流下降相关。
- 脑微透析乳酸/丙酮酸比值趋势分析可识别延迟性脑缺血高风险患者。
- 皮层扩散性去极化簇与临床神经功能恶化和脑梗死相关。
临床怎么用
- 对高风险患者可考虑使用侵入性神经监测检测延迟性脑缺血。
- 建议连续记录数据并结合趋势分析及多模态监测以支持个体化治疗。
局限性
- 现有研究存在设计偏倚,缺乏随机试验,结果推广至所有蛛网膜下腔出血患者受限。
- 未来试验应测试由侵入性神经监测触发的干预对脑梗死的影响。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND AND PURPOSE: Aneurysmal subarachnoid hemorrhage is a devastating disease leaving surviving patients often severely disabled. Delayed cerebral ischemia (DCI) has been identified as one of the main contributors to poor clinical outcome after subarachnoid hemorrhage. The objective of this review is to summarize existing clinical evidence assessing the diagnostic value of invasive neuromonitoring (INM) in detecting DCI and provide an update of evidence since the 2014 consensus statement on multimodality monitoring in neurocritical care. METHODS: Three invasive monitoring techniques were targeted in the data collection process: brain tissue oxygen tension (ptiO2), cerebral microdialysis, and electrocorticography. Prospective and retrospective studies as well as case series (≥10 patients) were included as long as monitoring was used to detect DCI or guide DCI treatment. RESULTS: Forty-seven studies reporting INM in the context of DCI were included (ptiO2: N=21; cerebral microdialysis: N=22; electrocorticography: N=4). Changes in brain oxygen tension are associated with angiographic vasospasm or reduction in regional cerebral blood flow. Metabolic monitoring with trend analysis of the lactate to pyruvate ratio using cerebral microdialysis, identifies patients at risk for DCI. Clusters of cortical spreading depolarizations are associated with clinical neurological worsening and cerebral infarction in selected patients receiving electrocorticography monitoring. CONCLUSIONS: Data supports the use of INM for the detection of DCI in selected patients. Generalizability to all subarachnoid hemorrhage patients is limited by design bias of available studies and lack of randomized trials. Continuous data recording with trend analysis and the combination of INM modalities can provide tailored treatment support in patients at high risk for DCI. Future trials should test interventions triggered by INM in relation to cerebral infarctions.
引用
- Veldeman M, Albanna W, Weiss M, et al. Invasive Multimodal Neuromonitoring in Aneurysmal Subarachnoid Hemorrhage: A Systematic Review. Stroke. 2021. PMID: 34304602. doi:10.1161/STROKEAHA.121.034633
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。